Psychological stress, vascular inflammation, and atherogenesis: Potential roles of circulating cytokines

Journal of Cardiovascular Pharmacology

Volumn 62, Issue 1, 2013, Pages 6-12

  Lu, Xiao Ting ^a   Zhao, Yu Xia ^a   Zhang, Yun ^a   Jiang, Fan ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

atherosclerosis; cardiovascular disease; cytokine; inflammation; interleukin 6; psychological stress; tumor necrosis factor a

Indexed keywords

ANGIOTENSIN; C REACTIVE PROTEIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUCOCORTICOID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; MACROPHAGE MIGRATION INHIBITION FACTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PADGEM PROTEIN; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

ADIPOCYTE; ATHEROGENESIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BRAIN VASCULITIS; CARDIOVASCULAR FUNCTION; CHRONIC STRESS; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIAL DYSFUNCTION; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MACROPHAGE; MEDIATOR RELEASE; MENTAL STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVIEW; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

ANIMALS; ATHEROSCLEROSIS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; STRESS, PSYCHOLOGICAL; VASCULITIS;

EID: 84880572088     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3182858fac     Document Type: Review

References (111)

1. von Kanel R. Psychosocial stress and cardiovascular risk: current opinion. Swiss Med Wkly. 2012;142:w13502.
2. Strike PC, Steptoe A. Psychosocial factors in the development of coronary artery disease. Prog Cardiovasc Dis. 2004;46:337-347.
3. Rozanski A, Blumenthal JA, Davidson KW, et al. The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. J Am Coll Cardiol. 2005;45:637-651.
4. Backe EM, Seidler A, Latza U, et al. The role of psychosocial stress at work for the development of cardiovascular diseases: a systematic review. Int Arch Occup Environ Health. 2012;85:67-79.
5. Clark AM, DesMeules M, Luo W, et al. Socioeconomic status and cardiovascular disease: risks and implications for care. Nat Rev Cardiol. 2009;6:712-722.
6. Steptoe A, Kivimaki M. Stress and cardiovascular disease. Nat Rev Cardiol. 2012;9:360-370.
7. Netterstrom B, Kristensen TS, Sjol A. Psychological job demands increase the risk of ischaemic heart disease: a 14-year cohort study of employed Danish men. Eur J Cardiovasc Prev Rehabil. 2006;13:414-420.
8. Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937-952.
9. Ohlin B, Nilsson PM, Nilsson JA, et al. Chronic psychosocial stress predicts long-term cardiovascular morbidity and mortality in middleaged men. Eur Heart J. 2004;25:867-873.
10. Andre-Petersson L, Engstrom G, Hedblad B, et al. Social support at work and the risk of myocardial infarction and stroke in women and men. Soc Sci Med. 2007;64:830-841.
11. Kuper H, Marmot M. Job strain, job demands, decision latitude, and risk of coronary heart disease within the Whitehall II study. J Epidemiol Community Health. 2003;57:147-153.
12. Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3:e442.
13. Rudisch B, Nemeroff CB. Epidemiology of comorbid coronary artery disease and depression. Biol Psychiatry. 2003;54:227-240.
14. Wulsin LR, Singal BM. Do depressive symptoms increase the risk for the onset of coronary disease? A systematic quantitative review. Psychosom Med. 2003;65:201-210.
15. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a metaanalysis. Psychosom Med. 2004;66:802-813.
16. Linden W, Phillips MJ, Leclerc J. Psychological treatment of cardiac patients: a meta-analysis. Eur Heart J. 2007;28:2972-2984.
17. Hobel CJ, Goldstein A, Barrett ES. Psychosocial stress and pregnancy outcome. Clin Obstet Gynecol. 2008;51:333-348.
18. Hasnain M, Vieweg WV, Lesnefsky EJ, et al. Depression screening in patients with coronary heart disease: a critical evaluation of the AHA guidelines. J Psychosom Res. 2011;71:6-12.
19. Goldstein DS, McEwen B. Allostasis, homeostats, and the nature of stress. Stress. 2002;5:55-58.
20. Black PH. Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun. 2002;16:622-653.
21. Hansel A, Hong S, Camara RJ, et al. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci Biobehav Rev. 2010;35:115-121.
22. Groeschel M, Braam B. Connecting chronic and recurrent stress to vascular dysfunction: no relaxed role for the renin-angiotensin system. Am J Physiol Renal Physiol. 2011;300:F1-F10.
23. de Jonge P, Rosmalen JG, Kema IP, et al. Psychophysiological biomarkers explaining the association between depression and prognosis in coronary artery patients: a critical review of the literature. Neurosci Biobehav Rev. 2010;35:84-90.
24. Hamer M, O'Donnell K, Lahiri A, et al. Salivary cortisol responses to mental stress are associated with coronary artery calcification in healthy men and women. Eur Heart J. 2010;31:424-429.
25. Alevizaki M, Cimponeriu A, Lekakis J, et al. High anticipatory stress plasma cortisol levels and sensitivity to glucocorticoids predict severity of coronary artery disease in subjects undergoing coronary angiography. Metabolism. 2007;56:222-226.
26. Dekker MJ, Koper JW, van Aken MO, et al. Salivary cortisol is related to atherosclerosis of carotid arteries. J Clin Endocrinol Metab. 2008;93: 3741-3747.
27. Matthews K, Schwartz J, Cohen S, et al. Diurnal cortisol decline is related to coronary calcification: CARDIA study. Psychosom Med. 2006;68:657-661.
28. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169:429-435.
29. Calandra T, Bernhagen J, Metz CN, et al. MIF as a glucocorticoidinduced modulator of cytokine production. Nature. 1995;377:68-71.
30. Girod JP, Brotman DJ. Does altered glucocorticoid homeostasis increase cardiovascular risk? Cardiovasc Res. 2004;64:217-226.
31. Kang MG, Koh SB, Cha BS, et al. Association between job stress on heart rate variability and metabolic syndrome in shipyard male workers. Yonsei Med J. 2004;45:838-846.
32. van Amelsvoort LG, Schouten EG, Maan AC, et al. Occupational determinants of heart rate variability. Int Arch Occup Environ Health. 2000;73:255-262.
33. Hemingway H, Shipley M, Brunner E, et al. Does autonomic function link social position to coronary risk? The Whitehall II study. Circulation. 2005;111:3071-3077.
34. Vrijkotte TG, van Doornen LJ, de Geus EJ. Effects of work stress on ambulatory blood pressure, heart rate, and heart rate variability. Hypertension. 2000;35:880-886.
35. Zanstra YJ, Schellekens JM, Schaap C, et al. Vagal and sympathetic activity in burnouts during a mentally demanding workday. Psychosom Med. 2006;68:583-590.
36. Jennings JR, Kamarck TW, Everson-Rose SA, et al. Exaggerated blood pressure responses during mental stress are prospectively related to enhanced carotid atherosclerosis in middle-aged Finnish men. Circulation. 2004;110:2198-2203.
37. Carroll D, Ginty AT, Der G, et al. Increased blood pressure reactions to acute mental stress are associated with 16-year cardiovascular disease mortality. Psychophysiology. 2012;49:1444-1448.
38. Malpas SC. Sympathetic nervous system overactivity and its role in the development of cardiovascular disease. Physiol Rev. 2010;90:513-557.
39. Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. J Psychosom Res. 2002;52:1-23.
40. Chung IM, Kim YM, Yoo MH, et al. Immobilization stress induces endothelial dysfunction by oxidative stress via the activation of the angiotensin II/its type I receptor pathway. Atherosclerosis. 2010;213:109-114.
41. Hamer M, Malan L, Schutte AE, et al. Plasma renin responses to mental stress and carotid intima-media thickness in black Africans: the SABPA study. J Hum Hypertens. 2011;25:437-443.
42. Heitzer T, Schlinzig T, Krohn K, et al. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104:2673-2678.
43. Mausbach BT, Roepke SK, Ziegler MG, et al. Association between chronic caregiving stress and impaired endothelial function in the elderly. J Am Coll Cardiol. 2010;55:2599-2606.
44. Broadley AJ, Korszun A, Jones CJ, et al. Arterial endothelial function is impaired in treated depression. Heart. 2002;88:521-523.
45. Kim JH, Kim JW, Ko YH, et al. Coronary endothelial dysfunction associated with a depressive mood in patients with atypical angina but angiographically normal coronary artery. Int J Cardiol. 2010;143: 154-157.
46. Neves VJ, Moura MJ, Tamascia ML, et al. Proatherosclerotic effects of chronic stress in male rats: altered phenylephrine sensitivity and nitric oxide synthase activity of aorta and circulating lipids. Stress. 2009;12: 320-327.
47. Strawn WB, Bondjers G, Kaplan JR, et al. Endothelial dysfunction in response to psychosocial stress in monkeys. Circ Res. 1991;68:1270-1279.
48. Williams JK, Kaplan JR, Manuck SB. Effects of psychosocial stress on endothelium-mediated dilation of atherosclerotic arteries in cynomolgus monkeys. J Clin Invest. 1993;92:1819-1823.
49. Sherwood A, Johnson K, Blumenthal JA, et al. Endothelial function and hemodynamic responses during mental stress. Psychosom Med. 1999; 61:365-370.
50. Spieker LE, Hurlimann D, Ruschitzka F, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation. 2002;105:2817-2820.
51. Nation DA, Gonzales JA, Mendez AJ, et al. The effect of social environment on markers of vascular oxidative stress and inflammation in the Watanabe heritable hyperlipidemic rabbit. Psychosom Med. 2008;70: 269-275.
52. Lu XT, Liu YF, Zhao L, et al. Chronic psychological stress induces vascular inflammation in rabbits. Stress. 2013;16:87-98.
53. Mangos GJ, Walker BR, Kelly JJ, et al. Cortisol inhibits cholinergic vasodilation in the human forearm. Am J Hypertens. 2000;13:1155-1160.
54. Kamarck TW, Shiffman S, Sutton-Tyrrell K, et al. Daily psychological demands are associated with 6-year progression of carotid artery atherosclerosis: the Pittsburgh Healthy Heart Project. Psychosom Med. 2012;74:432-439.
55. Fujishiro K, Diez Roux AV, Landsbergis P, et al. Associations of occupation, job control and job demands with intima-media thickness: the Multi-Ethnic Study of Atherosclerosis (MESA). Occup Environ Med. 2011;68:319-326.
56. Xu W, Hang J, Cao T, et al. Job stress and carotid intima-media thickness in Chinese workers. J Occup Health. 2010;52:257-262.
57. Wang HX, Leineweber C, Kirkeeide R, et al. Psychosocial stress and atherosclerosis: family and work stress accelerate progression of coronary disease in women. The Stockholm Female Coronary Angiography Study. J Intern Med. 2007;261:245-254.
58. Castillo-Richmond A, Schneider RH, Alexander CN, et al. Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans. Stroke. 2000;31:568-573.
59. Ranjit N, Diez-Roux AV, Shea S, et al. Psychosocial factors and inflammation in the multi-ethnic study of atherosclerosis. Arch Intern Med. 2007;167:174-181.
60. Ross R. Atherosclerosis an inflammatory disease. N Engl J Med. 1999;340:115-126.
61. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874.
62. Andersson IJ, Sankaralingam S, Davidge ST. Restraint stress up-regulates lectin-like oxidized low-density lipoprotein receptor-1 in aorta of apolipoprotein E-deficient mice. Stress. 2010;13:454-460.
63. Kumari M, Grahame-Clarke C, Shanks N, et al. Chronic stress accelerates atherosclerosis in the apolipoprotein E deficient mouse. Stress. 2003;6:297-299.
64. Li M, Wang X, Yang L, et al. Psychological stress increases expression of aortic plaque intercellular adhesion molecule-1 and seruminflammatory cytokines in atherosclerotic rabbit model. J Geriatr Cardiol. 2008;5:235-242.
65. McCabe PM, Gonzales JA, Zaias J, et al. Social environment influences the progression of atherosclerosis in the watanabe heritable hyperlipidemic rabbit. Circulation. 2002;105:354-359.
66. Bernberg E, Andersson IJ, Gan LM, et al. Effects of social isolation and environmental enrichment on atherosclerosis in ApoE-/-mice. Stress. 2008;11:381-389.
67. Bernberg E, Ulleryd MA, Johansson ME, et al. Social disruption stress increases IL-6 levels and accelerates atherosclerosis in ApoE-/-mice. Atherosclerosis. 2012;221:359-365.
68. d'Audiffret AC, Frisbee SJ, Stapleton PA, et al. Depressive behavior and vascular dysfunction: a link between clinical depression and vascular disease? J Appl Physiol. 2010;108:1041-1051.
69. Bernberg E, Andersson IJ, Tidstrand S, et al. Repeated exposure to stressors do not accelerate atherosclerosis in ApoE-/-mice. Atherosclerosis. 2009;204:90-95.
70. Isingrini E, Belzung C, d'Audiffret A, et al. Early and late-onset effect of chronic stress on vascular function in mice: a possible model of the impact of depression on vascular disease in aging. Am J Geriatr Psychiatry. 2011;19:335-346.
71. Lu XT, Liu YF, Zhang L, et al. Unpredictable chronic mild stress promotes atherosclerosis in high cholesterol-fed rabbits. Psychosom Med. 2012;74:604-611.
72. Deussing JM. Animal models of depression. Drug Discov Today. 2006; 3:375-383.
73. Marcondes MC, Zhukov V, Bradlow H, et al. Effects of chronic mental stress and atherogenic diet on the immune inflammatory environment in mouse aorta. Brain Behav Immun. 2011;25:1649-1657.
74. Zhang T, Chen Y, Liu H, et al. Chronic unpredictable stress accelerates atherosclerosis through promoting inflammation in apolipoprotein E knockout mice. Thromb Res. 2010;126:386-392.
75. Manuck SB, Kaplan JR, Adams MR, et al. Effects of stress and the sympathetic nervous system on coronary artery atherosclerosis in the cynomolgus macaque. Am Heart J. 1988;116:328-333.
76. Nerem RM, Levesque MJ, Cornhill JF. Social environment as a factor in diet-induced atherosclerosis. Science. 1980;208:1475-1476.
77. Finn AV, Nakano M, Narula J, et al. Concept of vulnerable/unstable plaque. Arterioscler Thromb Vasc Biol. 2010;30:1282-1292.
78. Ni M, Wang Y, Zhang M, et al. Atherosclerotic plaque disruption induced by stress and lipopolysaccharide in apolipoprotein E knockout mice. Am J Physiol Heart Circ Physiol. 2009;296:H1598-H1606.
79. Yasui T, Maegawa M, Tomita J, et al. Association of serum cytokine concentrations with psychological symptoms in midlife women. J Reprod Immunol. 2007;75:56-62.
80. von Kanel R, Bellingrath S, Kudielka BM. Association between burnout and circulating levels of pro-and anti-inflammatory cytokines in schoolteachers. J Psychosom Res. 2008;65:51-59.
81. Steptoe A, Owen N, Kunz-Ebrecht S, et al. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain Behav Immun. 2002;16:774-784.
82. Li S, Wang C, Wang W, et al. Chronic mild stress impairs cognition in mice: from brain homeostasis to behavior. Life Sci. 2008;82:934-942.
83. Grippo AJ, Francis J, Beltz TG, et al. Neuroendocrine and cytokine profile of chronic mild stress-induced anhedonia. Physiol Behav. 2005;84:697-706.
84. Schuett H, Luchtefeld M, Grothusen C, et al. How much is too much? Interleukin-6 and its signalling in atherosclerosis. Thromb Haemost. 2009;102:215-222.
85. Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease. Pharmacol Ther. 2002;94:123-135.
86. Rontgen P, Sablotzki A, Simm A, et al. Effect of catecholamines on intracellular cytokine synthesis in human monocytes. Eur Cytokine Netw. 2004;15:14-23.
87. Maes M, Lin A, Kenis G, et al. The effects of noradrenaline and alpha-2 adrenoceptor agents on the production of monocytic products. Psychiatry Res. 2000;96:245-253.
88. Lucini D, Di Fede G, Parati G, et al. Impact of chronic psychosocial stress on autonomic cardiovascular regulation in otherwise healthy subjects. Hypertension. 2005;46:1201-1206.
89. Tucker P, Pfefferbaum B, Jeon-Slaughter H, et al. Emotional stress and heart rate variability measures associated with cardiovascular risk in relocated Katrina survivors. Psychosom Med. 2012;74:160-168.
90. Borovikova LV, Ivanova S, Zhang M, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458-462.
91. Johnston GR, Webster NR. Cytokines and the immunomodulatory function of the vagus nerve. Br J Anaesth. 2009;102:453-462.
92. Tracey KJ. Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest. 2007;117:289-296.
93. Skurk T, van Harmelen V, Hauner H. Angiotensin II stimulates the release of interleukin-6 and interleukin-8 from cultured human adipocytes by activation of NF-kappaB. Arterioscler Thromb Vasc Biol. 2004;24:1199-1203.
94. Tsuchiya K, Yoshimoto T, Hirono Y, et al. Angiotensin II induces monocyte chemoattractant protein-1 expression via a nuclear factorkappaB-dependent pathway in rat preadipocytes. Am J Physiol Endocrinol Metab. 2006;291:E771-E778.
95. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord. 1998;22:1145-1158.
96. Bose M, Olivan B, Laferrere B. Stress and obesity: the role of the hypothalamic-pituitary-adrenal axis in metabolic disease. Curr Opin Endocrinol Diabetes Obes. 2009;16:340-346.
97. Kuo LE, Czarnecka M, Kitlinska JB, et al. Chronic stress, combined with a high-fat/high-sugar diet, shifts sympathetic signaling toward neuropeptide Y and leads to obesity and the metabolic syndrome. Ann N Y Acad Sci. 2008;1148:232-237.
98. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
99. Genest J. C-reactive protein: risk factor, biomarker and/or therapeutic target? Can J Cardiol. 2010;26(suppl A):41A-44A.
100. Bisoendial RJ, Boekholdt SM, Vergeer M, et al. C-reactive protein is a mediator of cardiovascular disease. Eur Heart J. 2010;31:2087-2091.
101. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension. 2004;44:6-11.
102. Lahlou-Laforet K, Alhenc-Gelas M, Pornin M, et al. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease. Am J Cardiol. 2006;97:1287-1291.
103. Brostedt EM, de Faire U, Westerholm P, et al. Job strain and plasminogen activator inhibitor-1: results from the Swedish WOLF study. Int Arch Occup Environ Health. 2004;77:341-344.
104. Warshofsky MK, Wasserman HS, Wang W, et al. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients. Am J Cardiol. 1997;80:145-149.
105. Scarabin PY, Aillaud MF, Amouyel P, et al. Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction. Thromb Haemost. 1998;80:749-756.
106. Segarra A, Chacon P, Martinez-Eyarre C, et al. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis. J Am Soc Nephrol. 2001;12:1255-1263.
107. Peng Y, Liu H, Liu F, et al. Atherosclerosis is associated with plasminogen activator inhibitor type-1 in chronic haemodialysis patients. Nephrology (Carlton). 2008;13:579-586.
108. Eitzman DT, Westrick RJ, Xu Z, et al. Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood. 2000;96:4212-4215.
109. Orth-Gomer K, Schneiderman N, Wang HX, et al. Stress reduction prolongs life in women with coronary disease: the Stockholm Women's Intervention Trial for Coronary Heart Disease (SWITCHD). Circ Cardiovasc Qual Outcomes. 2009;2:25-32.
110. Williams RB. Psychosocial and biobehavioral factors and their interplay in coronary heart disease. Annu Rev Clin Psychol. 2008;4:349-365.
111. Miller GE, Chen E, Parker KJ. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull. 2011;137:959-997.